MedTrace Logo

Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer

NCT05356039 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2022-11-30

No results posted yet for this study

Summary

This study aims to assess overall survival, quality of life and resection rates in locally advanced pancreatic cancer

Conditions

  • Pancreas Cancer
  • Pancreas Neoplasm
  • Pancreas Disease
  • Pancreas Adenocarcinoma
  • Surgery
  • Chemotherapy Effect
  • Quality of Life
  • Locally Advanced Pancreatic Adenocarcinoma
  • Borderline Resectable Pancreatic Adenocarcinoma

Sponsors & Collaborators

  • University Hospital, Linkoeping

    collaborator OTHER

  • Lund University Hospital

    collaborator OTHER

  • Sahlgrenska University Hospital

    collaborator OTHER

  • Karolinska University Hospital

    collaborator OTHER

  • University Hospital, Umeå

    collaborator OTHER

  • Umeå University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-19
Primary Completion
2025-05-31
Completion
2028-05-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05356039 on ClinicalTrials.gov